N‒substituted 5‒hydroxy‒pyrrol‒2‒ones based cholecystokinin‒2 antagonists as experimental anticancer agents for the treatment of lung cancer
-
Published:2018-07-06
Issue:4
Volume:2
Page:
-
ISSN:2575-9094
-
Container-title:MOJ Drug Design Development & Therapy
-
language:
-
Short-container-title:MOJDDT
Publisher
MedCrave Group, LLC
Subject
Ocean Engineering
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献